eMedCodes logo

Avastin - bevacizumab

Navigation: NDC > Supplier starting with: G > GENENTECH, INC.
Field Value
NDC Code: 50242-060
Proprietary Name: Avastin
Suffix:
Non-Proprietary Name: bevacizumab
Dosage Form: INJECTION, SOLUTION
Method: INTRAVENOUS
Original Marketing Date: 26-02-2004
Category Name: BLA
Application Number: BLA125085
Labeler: GENENTECH, INC.
Substance Name: BEVACIZUMAB
Active Numerator Strength: 100
Active Ingredient Unit: mg/4mL
Pharm Classes: Vascular Endothelial Growth Factor Receptor Inhibitors [MoA],Vascular Endothelial Growth Factor-directed Antibody [EPC],Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
DEA Schedule: